Retaglutide and tirzepatide are innovative GLP-1 receptor agonists gaining attention as effective treatment options for type 2 diabetes. These medications promote insulin secretion from the pancreas, suppress glucagon https://neiljjuf349468.blogdigy.com/emerging-therapies-for-type-2-diabetes-61248750